Bevorzugung von Importarzneimitteln beenden - Arzneimittelsicherheit verbessern

This procedure aims to enhance drug safety within Germany by addressing the preferential treatment given to imported medicines. The goal is to ensure that all medicines available on the market meet the highest safety standards, regardless of their origin. This change would primarily affect pharmaceutical companies, regulatory bodies, and ultimately, patients in Germany, by potentially altering the availability and cost of certain imported medications.